Loading...
CNSP CNS PHARMACEUTICALS INC Expansion Plans 8-K Filing
Back
CNS
CNSP
CNS PHARMACEUTICALS INC
(CNSP)
Follow
FY2024 8 K
View More
Back
CNS
CNSP
CNS PHARMACEUTICALS INC
(CNSP)
Follow
FY2024 8 K
Filing:
8 K
Published on:
23 Oct '24
Public Offering
9 Apr '25
Clinical Trial Update
31 Mar '25
New Contract
20 Mar '25
New Contract
21 Feb '25
Financial Update
3 Jan '25
Equity Offering
11 Dec '24
Earnings Report
2 Dec '24
Clinical Trial Update
1 Nov '24
Capital Raise
24 Oct '24
Clinical Trial Update
23 Oct '24
Financial Update
18 Sep '24
Capital Raise
12 Sep '24
Financial Data
7 Aug '24
Quantitative Data
30 Jul '24
Filing Letter with Quantita...
30 Jul '24
US FDA Inspection
26 Jul '24
Expansion Plan
24 Jul '24
Filing with Quantitative Data
11 Jul '24
Appointment
9 Jul '24
Securities Purchase Agreements
3 Jul '24
Securities Purchase Agreements
26 Jun '24
Filing with Quantitative Data
20 Jun '24
Securities Purchase Agreements
14 Jun '24
Filing Letter
5 Jun '24
Filing Letter
16 May '24
Quantitative Data
7 May '24
8-K Filing
3 May '24
Clinical Trial Update
12 Apr '24
Filing Letter
1 Apr '24
Clinical Trial Update
27 Feb '24
Update on Berubicin Phase 2...
21 Feb '24
Public Offering
2 Feb '24
Product Update
23 Jan '24
Update on Drug Candidate
21 Dec '23
8-K Filing
18 Dec '23
Clinical Trial Update
15 Nov '23
Clinical Trial Update
18 Oct '23
Warrant Exercise
17 Oct '23
Expansion Plan
18 Aug '23
Other Special Situation
15 Aug '23
Management Changes
14 Aug '23
Clinical Trial Update
15 May '23
Clinical Trial Update
8 May '23
Earnings Reports
3 Jan '23
External Links:
SEC
AI Assistant
Close
CNS PHARMACEUTICALS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.